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Abstract
Background: Most research concerning congenital adrenal hyperplasia (CAH) and related conditions caused by
primary adrenal insufficiency, such as Addison’s or Cushing’s disease, has focused on medical aspects rather than
on patients’ quality of life. Therefore, our objective was to investigate the physical, social and societal functioning
of children with CAH and their parents in a Dutch population.
Methods: The study is descriptive and cross-sectional. Self-designed questionnaires, based on questionnaires
developed in the Netherlands for different patient groups, were sent to parents of children with CAH between 0
and 18 years old. Participants were recruited through the Dutch patient group for Adrenal Disease (NVACP) and six
hospitals in the Netherlands. Three different questionnaires were designed for parents: for children aged 0 - 4,
aged 4 - 12 and aged 12 - 18. Additionally, a fourth questionnaire was sent to adolescents with CAH aged 12 - 18.
Main outcome measures were experienced burden of the condition, self-management and participation in several
areas, such as school and leisure time.
Results: A total of 106 parents returned the questionnaire, 12 regarding pre-school children (0-4 years), 63
regarding primary school children (4-12 years), and 32 regarding secondary school children (12-18 years), combined
response rate 69.7%. Also, 24 adolescents returned the questionnaire. Children and adolescents with CAH appear to
be capable of self-management at a young age. Experienced burden of the condition is low, although children
experience several health related problems on a daily basis. Children participate well in school and leisure time.
Few children carry a crisis card or emergency injection with them.
Conclusions: Overall, our research shows that, according to their parents, children with CAH experience few
negative effects of the condition and that they participate well in several areas such as school and leisure time.
However, improvements can be made concerning the measures parents and children must take to prevent an
adrenal crisis.
Keywords: CAH, children, quality of life, social functioning, burden of disease, self-management, participation,
Netherlands, parents, comorbidity, preventive measures
Background
Congenital Adrenal Hyperplasia (CAH) is an inherited
disorder of the adrenal cortex caused by deficiency of
enzymes involved in adrenal steroidogenesis, most often
a deficiency of 21-hydroxylase [1-4]. This defect results
in an impaired production of cortisol and mostly also of
aldosterone and an excessive production of adrenal
androgens. The clinical picture depends on the degree of
the enzymatic block: the most severe form, the classic
CAH (almost always apparent at birth) and the mild non-
classic form (mostly diagnosed later in life). In general,
CAH has larger implications for females than males.
Furthermore, the classical form is subclassified in the salt
wasting (SW) and the simple virilising form (SV) [3].
Females with the classic form of CAH are born with
ambiguous external genitalia caused by the excessive
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amount of androgens already in utero [3,5]. In these
cases, surgery is often necessary to correct the external
genitalia. Treatment of CAH consists of long-term gluco-
corticoid and mostly also mineralocorticoid substitution
[6]. Increased dosages of glucocorticoids are necessary in
case of physical stress to prevent life threatening Addiso-
nian (adrenal) crisis. Overtreatment can lead to growth
inhibition, excess weight, and several daily health related
problems such as sleepiness and abdominal pain. Under-
treatment can lead to symptoms of androgen excess such
as signs of early puberty, early growth acceleration and
reduced final height. In the Netherlands, the prevalence
of CAH is about 1 in 12.000. Every year, 15 to 20 infants
are newly diagnosed with the disorder [7]. Since 2000,
CAH is part of the neonatal screening programme in the
Netherlands to prevent life threatening Adrenal crisis.
Studies focussing on quality of life in patients with
adrenal diseases are rare. Only recently some studies
have been published about the quality of life of adult
patients with Addison’s disease. Most of these studies
have shown a reduced quality of life, especially in adult
patients with comorbidity. Furthermore, a recent study
[8] found that the objective and subjective health status
in adult CAH patients in the United Kingdom was signif-
icantly impaired. However, no research has been carried
out to study the quality of life of children with primary
adrenal insufficiency.
The aim of our study is to investigate the quality of
life of children and adolescents with CAH and their par-
ents by studying physical, social and societal functioning
of children with CAH and their parents.
Methods
Subjects
Parents of children with all types of CAH were recruited
through the Dutch patient group Adrenal Disease
(NVACP). Additionally, several hospitals in the Nether-
lands were asked to inform their patients about the
research. A total of six hospitals participated in the study,
five university hospitals and one general hospital.
Assessments
Self designed questionnaires, based on questionnaires
developed in the Netherlands for different patient groups,
were used to measure the following sub-concepts: social
demographics (i.e. sex, age, parents’ education, country of
origin), characteristics of the condition (i.e. CAH subtype,
comorbidity, CAH-medication use), experienced burden
of the condition (physical and mental problems, con-
straints, adrenal crisis), self management (lifestyle, social
support, general medication use) and participation in sev-
eral areas such as school and leisure time. The questions
were derived from the Second National Survey of General
Practice (DNSGP-2) [9], a Dutch study concerning quality
of life of (adult) patients with Addison’s disease, Cushing’s
disease and CAH [10] and a Dutch study concerning
young adults with chronic digestive disorders [11].
Three different questionnaires were developed for par-
ents of different age groups. A questionnaire for parents of
children aged 0 - 4, 4 - 12 and 12 - 18. This distinction
was based on the Dutch schooling system. Children aged
0 - 4 do not go to school yet, children aged 4 - 12 receive
primary education and children aged 12 - 18 receive sec-
ondary education. The questionnaires were largely the
same, except for some age-specific questions, for instance,
about school, work and going out. Adolescents of 12 - 18
years were also invited to fill out a questionnaire them-
selves [12].
Study design
In this study, quality of life is defined according to the
sub-concepts used by Heijmans et al [10] in a Dutch
report about the impact of Addison’s disease, Cushing’s
disease and CAH on the daily life of adult patients. The
sample of CAH patients in that study was too small to
draw conclusions from and children were excluded.
An exploratory design was used to describe the several
sub-concepts (see assessments).
Parents and adolescents had the possibility to fill out a
paper version or an online version of the questionnaire.
For the online version, they received a link to the ques-
tionnaire by email. A first reminder was sent after 2-3
weeks. If needed, a second reminder was sent again 2-3
weeks later.
Ethical approval
Ethical approval is not required for this kind of study in
the Netherlands.
Analysis
Due to the division in three separate age groups, the num-
ber of subjects in each age group was relatively small,
which hampered the use of statistical models. Therefore,
the results are mainly descriptive. Each concept was
described for each group and groups were compared to
study possible differences on the various concepts. Six (for
age group 0-4) or seven (for both other age groups) ques-
tions have been combined in order to create the scale
‘Parents’ experiences’. Eight questions were combined to
create the scale ‘Difficulties’. The reliability of these scales
is expressed in Cronbach’s alpha. Where possible, compar-
isons were made with data from the second Dutch
National Survey of General Practice (DNSGP-2). DNSGP-
2 is a Dutch nationwide study, containing representative
information on morbidity in the population, use of health
services at patient level, health determinants and sociode-
mographic characteristics [9]. DNSGP-2 contains data
about approximately 50.000 children in the Netherlands,
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which makes it a very powerful dataset for comparison. All
analyses were carried out with Stata 10.
Results
Response
250 invitations were sent to parents of children with
CAH with information about the study and 152 parents
enrolled and received a questionnaire. Of those ques-
tionnaires 106 were returned fully completed (response
rate of 69.7%). Twelve questionnaires were returned by
parents of children of 0-4 years, 62 for children of 4-12
years and 32 for adolescents 12-18 years of age. Adoles-
cents themselves returned 24 questionnaires.
Sample characteristics
Parent questionnaires
Sample characteristics are listed in Table 1. The groups
0-4 and 4-12 consisted of slightly more boys than girls.
This was reversed in the group 12-18. The age distribu-
tion within the groups was skewed. Children under the
age of 1 year were not represented in the youngest age
group. The middle age group was relatively old with 69%
of children being over 7 years old. On the other hand,
the oldest age group was relatively young with almost
63% of children being under 15 years old. The mean age
of children in the group 0-4 was 2.4 years, in the middle
age group 8.5 years and in the oldest age group 15.0
years. Most children (75%) had the salt wasting type of
CAH, only 5% of children had the nonclassic type of
CAH. In all age groups, boys were more often diagnosed
as salt wasters than girls (boys ≥ 80% SW, girls 50-75%
SW). The time from the first symptoms until the
definitive diagnosis was shorter for younger children than
for older children. Furthermore, younger children experi-
enced fewer health related problems before the time of
diagnosis than older children.
Adolescent questionnaires
Sample characteristics are listed in Table 2. 24 question-
naires were returned (62.5% girls). 79% indicated to
have reached puberty. 79.2% had salt wasting CAH,
8.3% SV CAH and 1 person (4.2%) had the nonclassic
form of CAH. 33% of adolescents reported to experience
no daily health related problems, 17% experienced one,
13% two, 4% three, and 33% more than four daily health
related problems.
Health related problems at diagnosis
Health related problems often mentioned by parents in
all age groups are weight loss, severe somnolence, accel-
erated growth/development, inability to retain fluids and
lack of appetite. About 31% of the children had CAH
related complications in the neonatal period. Genital
anomalies occurred most often, dehydration due to loss
of salt was second. Girls in the younger age groups more
often underwent reconstructive surgery than in the older
group. One parent of a child aged 0-4 years was dissatis-
fied with the results of the operation, whereas all other
parents of operated children (n = 24) were satisfied with
the results of the operation.
Current health related problems and comorbidity
Table 3 shows the number of daily health related pro-
blems and the incidence of chronic conditions beside
CAH such as asthma or eczema in the sample from the
parent questionnaires compared to data from DNSGP-2.
Although chronic conditions in addition to CAH were
Table 1 Sample characteristics and characteristics of the condition from parent questionnaires
0-4 year 4-12 year 12-18 year Total
n (%) n (%) n (%) n (%)
Total 12 (100) 62 (100) 32 (100) 106 (100)
Sex
Male 7 (58) 34 (55) 15 (47) 56 (53)
Female 5 (42) 28 (45) 17 (53) 50 (47)
CAH subtype
Salt wasting form 9 (75) 50 (81) 21 (66) 80 (75)
Simple virilizing form 3 (25) 9 (14) 8 (25) 20 (19)
Non-classical form 0 - 3 (5) 2 (6) 5 (5)
Unknown 0 - 0 - 1 (3) 1 (1)
Diagnosis
Within 1 week after birth 11 (92) 45 (73) 12 (38) 68 (64)
Health related problems before diagnosis
Yes 6 (50) 42 (68) 24 (75) 72 (70)
Complications at birth
Yes 5 (42) 19 (31) 9 (28) 33 (31)
Reconstructive surgery (girls) n = 5 n = 28 n = 17 n = 50
Yes 3 (60) 15 (54) 6 (35) 24 (48)
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rare in the study population, 71% of the children experi-
enced daily health related problems in the two weeks
preceding the questionnaire. The daily health related
problems that occurred most often in children with
CAH were excessive sweating, mood swings, lack of
energy, excitability, fever, sleepiness, crying and pain in
the legs and abdomen. However, in all age groups, chil-
dren with CAH seem to have less daily health related
problems than their peers in DNSGP-2 but this finding
was not tested for significance. Only children aged 4-12
seem to have more daily health related problems than
the other age groups and than children from DNSGP-2.
Experienced burden of the condition
Only 8% of the parents reported that their children
experienced constraints in daily life as a result of CAH
(Table 4). According to the parents, an adrenal crisis
was experienced by 33% of the children. Most parents
(83%) indicated that they did not fear the occurrence of
an adrenal crisis. About 30% of children aged 4-18 have
been absent of school due to CAH in the past year. The
percentage of parents feeling their actions can influence
the course of the condition declines when the age of the
children increases. In total, 96% of the parents indicated
to be satisfied with the overall health of their children.
All adolescents were satisfied with their own health and
84% of them have no problem with controlling the con-
dition (not shown in Table).
Two scales have been constructed about parents’
experiences (Table 5). The scale ‘Experiences parents’
contains items about parents’ experience with the condi-
tion of their child (including their own ability to control
the condition). The average score on this scale in all
three age groups is slightly higher than 3, which indicates
that parents are inclined to a more positive feeling. The
scale ‘Difficulties’ contains items about the reasons why
parents find it difficult to keep the condition of their
child under control, including an item about their fear of
an adrenal crisis. The average score on this scale is below
Table 2 Sample characteristics and characteristics of the
condition from adolescent questionnaires
Adolescents
n (%)
Total 24 (100)
Sex
Male 9 (37.5)
Female 14 (62.5)
Age
12 - 15 14 (62.5)
15 - 18 9 (37.5)
Reached puberty
Yes 19 (79)
No 5 (21)
CAH subtype
Salt wasting form 19 (79)
Simple virilizing form 2 (8)
Non-classical form 1 (4)
Unknown 2 (8)
Number of daily health-related problems
0 8 (33)
1 4 (17)
2 3 (13)
3 1 (4)
≥ 4 8 (33)
Table 3 Comorbidity and number of daily health-related problems (according to parents) in children with CAH and
control children from DNSGP-2
0-4
CAH
0-4
DNSGP-2
4-12
CAH
5-12
DNSGP-2
12-18
CAH
13-18
DNSGP-2
total
CAH
total
DNSGP-2
chronic conditions *
0 0.0 71.8 0.0 70.6 0.0 65.4 0.0 69.3
1 83.0 24.0 72.6 21.7 78.0 23.7 77.9 23.1
≥ 2 17.0 4.2 27.4 7.7 22.0 10.9 22.1 7.6
Total 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0
N 12 766 62 1494 32 874 106 3134
Number of daily health-related problems
0 42.0 17.0 26.0 20.6 31.0 8.7 33.0 15.4
1 16.6 20.9 6.0 21.9 16.0 16.4 12.9 19.7
2 8.0 19.3 18.0 16.9 19.0 15.2 15.0 17.1
3 16.6 14.9 10.0 12.5 12.0 14.3 12.9 13.9
≥ 4 16.6 27.9 40.0 28.1 22.0 45.4 26.2 33.8
Total 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0
N 12 766 62 1494 32 874 106 3134
* chronic conditions, including CAH
Age boundaries differ slightly between CAH groups and DNSGP-2 groups.
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3 for all age groups. This means that on average, parents
do not find it difficult to keep the condition of their child
under control. The same holds true for the adolescents
who have a mean score of 2.03 on the ‘Difficulties’ scale
(not in Table).
Management
About 6% of children older than 4 years do not use medi-
cation daily (Table 6). On the other hand, 82% of chil-
dren use two or more different medicines for CAH, most
often Hydrocortisone and Fludrocortisone. Approxi-
mately 88% of the parents report that a proper balance in
medication use is achieved. Medication is administered at
a set time by 83% of the parents. The percentage of par-
ents that administer medication at fixed times declines
when children get older. Of the adolescents, 17% (n = 4)
indicate not to use any CAH related medication (not in
Table). All of the children and adolescents that do not
use medication (or, in case of the adolescents, say they
do not use medication) have the classic form of CAH.
Medication is most often raised in response to flu, fever,
physical injury, and illness in general (Table 6). Parents
of children younger than 12 years often mentioned
inoculation or drawing blood as a reason to increase the
medication whereas parents of children older than 12
years often mentioned exams as a reason to increase the
medication.
Self-management
Almost 63% of children aged 4-12 take their medicines
independently or with some support of their parents and
56% of children aged 12-18 take their medication indepen-
dently, according to their parents. 63% of the adolescents
indicate that they take their medication independently
from their parents and 38% of those adolescents receive
help from a parent or other family member. The mean age
at which children start to self-administer medication is 7.6
years (CI: 6.81 - 8.48). Approximately 67% of parents of
children aged 12-18 years check whether the medication
has been taken correctly. Approximately 75% of the ado-
lescents take their medication according to the instruc-
tions of their physician.
Preventive measures
The measures that children and their parents take to pre-
vent an adrenal crisis were also investigated. Only 7 of
106 children were able to inject themselves glucocorti-
coids intramuscularly in case of an adrenal crisis. On
Table 4 Experienced burden of the condition (by parents)
0-4 year 4-12 year 12-18 year Total
n (%) n (%) n (%) n (%)
Total 12 (100) 62 (100) 32 (100) 106 (100)
Constraints in daily life
((totally) agree)
0 - 6 (10) 2 (6) 8 (8)
Adrenal crisis experienced (yes) 3 (25) 20 (32) 12 (38) 35 (33)
Fear for adrenal crisis
((totally) agree)
3 (25) 15 (24) 0 - 18 (17)
School absence due to CAH (yes) n/a - 19 (31) 9 (28) 28 (30)
Influence on condition
((totally) agree)
9 (75) 38 (61) 19 (59) 66 (62)
General health
(good/very good/excellent)
12 (100) 60 (97) 30 (94) 102 (96)
n/a = not applicable
Table 5 Parents’ experience with the condition
0-4 year 4-12 year 12-18 year
Scale ‘Experiences parents’
Average scale score (95% CI) 3.50 (3.06-3.94) 3.08 (2.92-3.25) 3.22 (2.94-3.50)
Cronbach’s alpha 0.76 0.71 0.72
Number of items (range)
1———————————— 3 ——————————5
Negative neutral positive
6 (1-5) 7 (1-5) 7 (1-5)
Scale ‘Difficulties’
Average scale score (95% CI) 2.18 (1.80-2.55) 2.27 (2.12-2.42) 1.82 (1.61-2.03)
Cronbach’s alpha 0.78 0.73 0.85
Number of items (range)
1————————————3 ——————————5
Less diff. neutral more diff.
8 (1-5) 8 (1-5) 8 (1-5)
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average 59% of all children carry an SOS bracelet or
badge, children aged 4-12 more often (66%) than older
(59%) or younger (25%) children. More than half of the
adolescents carry an SOS bracelet or badge. However,
only 17% carry a crisis card or emergency injection.
According to parents, 31% of children aged 12-18 always
carry a crisis card or emergency injection with them. For
the younger age groups, parents most often carry a crisis
card or emergency injection with them. Most parents of
children with CAH state that their children’s friends are
aware of the fact that their child has a chronic medical
condition.
Participation
As shown in Table 4 in the past 12 months, 30% of chil-
dren have been absent from school for CAH related rea-
sons. The average duration of school absence was
approximately 7 days. 32% of the parents had contact
with school because of school problems in the past 12
months. The reasons for contact varied from providing
information and education to teachers to problems with
bullying, behavioural problems and problems caused by
comorbidity such as autism or dyslexia. With regard to
physical exercise, 67% of the parents indicate that their
child exercises just as much as peers without CAH
(Table 6). Furthermore, 82% of children engage in a
sport, often mentioned are horse riding, swimming, soc-
cer and tennis. About 84% of parents of children older
than 4 years indicate that their children have one or
more hobbies. Playing outdoors, and playing computer
games are often mentioned among children aged 4-12
and playing outdoors, meeting with friends, playing
computer games and playing a musical instrument are
often mentioned among children aged 12-18. About
28% of children older than 12 have a part time job next
to school. On average they work 5.8 (+/-1.26) hours a
week. According to their parents, none of these children
experience problems at work as a consequence of CAH.
To evaluate the degree of protectiveness or even over-
protectiveness that parents may display towards their
children, some questions were asked only to parents of
children of certain age groups. Firstly, parents of chil-
dren aged 0-4 were asked if they make use of child care
facilities and 75% indicated to do so. A playgroup or day
nursery was mentioned most often. Secondly, parents of
children aged 4-12 were asked whether their child
sometimes spends the night away from home, for exam-
ple, with family or friends. About 85% of parents
reported that this sometimes occurred.
None of the adolescents indicated to experience impedi-
ments like concentration problems, physical discomfort or
pain. When asked how they would rate their own level of
functioning in daily life, all adolescents reported to be
satisfied, with answers varying from good (35%) to very
good (30%) and excellent (35%).
Finally, parents of children aged 12-18 were asked if
their children go out by themselves or whether they go on
holiday independent of their parents. Less than half of the
children (41%) go out by themselves and 69% has occa-
sionally been on holiday independent of their parents.
Unfortunately, for these participation questions we have
no comparative data available from the general population.
Table 6 Self management and Participation (according to parents)
0-4 year 4-12 year 12-18 year Total
n (%) n (%) n (%) n (%)
Total 12 (100) 62 (100) 32 (100) 106 (100)
Self management
Daily medication use
0 CAH med. 0 - 4 (6) 2 (6) 6 (6)
1 CAH med. 0 - 7 (11) 6 (19) 13 (12)
2 CAH meds. 9 (75) 29 (47) 11 (34) 49 (46)
3 CAH meds. 3 (25) 22 (36) 13 (41) 38 (36)
Medication at fixed time 11 (92) 53 (85) 24 (75) 88 (83)
Increased medication in past 12 months?
0 times 0 - 3 (5) 5 (16) 8 (7.5)
1-10 times 11 (92) 43 (69) 19 (59) 73 (69)
> 10 times 1 (8) 11 (18) 5 (16) 17 (16)
Unknown 0 - 5 (8) 3 (9) 8 (7.5)
Participation
Contact with school because of problems n/a - 22 (35) 8 (25) 30 (32)
Child exercises as much as peers without CAH n/a - 41 (66) 22 (69) 63 (67)
Child engages in a sport n/a - 46 (74) 31 (97) 77 (82)
n/a = not applicable
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Discussion
In this study, we evaluated the physical, social and societal
functioning of children with CAH and their parents. Pre-
vious research has focused mainly on adult patients with
Addison’s disease and CAH so to our knowledge this
study is the first describing health state and quality of life
of children with CAH and their parents.
In general, our results show that children with CAH
experience few negative CAH related effects and that they
participate well in several areas such as school and leisure
time. Adolescents are confident about the management of
their condition and their participation in daily life. Parents
do not seem to be exceptionally protective of their chil-
dren and are capable of leaving the care of their child to
others.
Depending on the tools used mixed results are found
but previous studies in Norway [13,14], Germany [15,16]
and the United Kingdom [8,17] have shown impaired
quality of life in adult patients with Addison’s disease and
CAH. Particularly, reduced energy, vitality and general
health perception were reported. The parents of children
with CAH in our population, however, did not report any
of these problems. Instead, most parents indicated they
were satisfied with the general health of their child with
CAH. Comorbidity was present in most adult CAH
patients studied by Erichsen [13]. In contrast, in our popu-
lation comorbidity was scarce. That may explain the
absence of impaired quality of life in our group children.
Recently, Arlt et al. described the health status of adult
CAH patients in the United Kingdom [8] and showed that
a minority of adult CAH patients in the United Kingdom
are under endocrine specialist care and that androgen
levels are often poorly controlled whereas children with
CAH are managed using established guidelines. This may
be another important factor in explaining the higher qual-
ity of life in children compared to adults. Our results show
some discrepancy between the answers of parents of ado-
lescents and adolescents themselves with regard to medi-
cation intake. 17% of adolescents indicate not to use any
CAH related medication compared to only 6% indicated
by their parents. This may be explained by the assumption
that parents may not be aware of the fact that their child
has stopped taking medication.
Our results show that as children grow older, parents
become less afraid of an adrenal crisis. This is probably
because parents get more familiar with the disease.
When children grow older, the responsibility for the
management shifts from parent to child, as is the case in
all chronic conditions and healthy children. This transfer
of responsibility and control is often difficult for parents
as their role in managing the disease decreases [18]. We
found that the increasing importance of self-management
seems to pose few problems for children with CAH since
they are partly capable of self-management already at a
young age. However, measures to prevent adrenal crisis
can be improved. Although CAH patients have to carry a
card or SOS bracelet that indicates the use of glucocorti-
coids in case an emergency occurs, our results show that
many children don’t do so It is important to stress the
necessity of such preventive measures.
A limitation of our study is a lack of a reference group
of healthy children for all variables. Furthermore, we
used questionnaires adapted from a previous Dutch
study [16] that hinders comparisons to other studies.
Because group sizes were relatively small detailed sta-
tistical models could not be used.
Conclusions
In conclusion, our study shows that quality of life is not
reduced in children with CAH and their parents. The
children do experience several daily health related pro-
blems but these do not hamper them in their daily
activities and participation in society. Parents themselves
do not experience a lot of fear about the occurrence of
an adrenal crisis and feel that they can influence the
condition of their child. However, measures for preven-
tion of adrenal crisis could be improved.
Acknowledgements
The authors wish to thank the Dutch Society for Addison and Cushing
patients (NVACP), especially Alida Noordzij, Esther Groenhuijzen and Martijn
van der Lee, the specialists and hospitals and all parents of children with
CAH for their cooperation in this study. This study was made possible
through financial support from the Dutch patient group for Addison,
Cushing and CAH patients (NVACP) and fonds Nuts/Ohra.
Author details
1Netherlands institute for health services research (NIVEL), P.O. Box 1568,
3500 BN Utrecht, The Netherlands. 2VU Medical Centre, department of
Rehabilitation Medicine, room PK -1 Y 158, De Boelelaan 1118, 1081 HZ, The
Netherlands. 3Department of Paediatric Endocrinology, Radboud University
Nijmegen Medical Centre, P O Box 9101, 6500 HB Nijmegen, The
Netherlands.
Authors’ contributions
SS and TW designed the questionnaires and conducted the study. SS
drafted the manuscript and performed the statistical analysis. TW helped to
draft the manuscript. HC and BO participated in the design of the
questionnaires, participation of patients and revised the manuscript. All
authors read and approved the final manuscript.
Competing interests
There are no potential conflicts of interest with respect to financial or
personal relationships.
Received: 21 July 2011 Accepted: 2 February 2012
Published: 2 February 2012
References
1. Trakakis E, Loghis C, Kassanos D: Congenital Adrenal Hyperplasia Because
of 21-Hydroxylase Deficiency. A Genetic Disorder of interest to
Obstetrics and Gynecologists. Obstet Gynecol Surv 2009, 64:177-187.
2. Claahsen- van der Grinten HL: Van gen naar ziekte; het adrenogenitaal
syndroom en het CYP21A2-gen (From gene to disease: adrenogenital
Sanches et al. International Journal of Pediatric Endocrinology 2012, 2012:2
http://www.ijpeonline.com/content/2012/1/2
Page 7 of 8
syndrome and the CYP21A2 gene). Nederlands tijdschrift voor geneeskunde
2007, 151(Suppl 21):1174-1177.
3. Grosse SD, Van Vliet G: How many deaths can be prevented by newborn
screening for Congenital Adrenal Hyperplasia? Horm Res 2007,
67:284-291.
4. Bachelot A, Chakthoura Z, Rouxel A, Dulon J, Touraine P: Classical Forms of
Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency in
Adults. Horm Res 2008, 69:203-211.
5. Malouf MA, Inman AG, Carr AG, Franco J, Brooks LM: Health-related quality
of life, mental health and psychotherapeutic considerations for women
diagnosed with a disorder of sexual development: Congenital Adrenal
Hyperplasia. Int J Ped Endcorinol 2010, 2010:253465.
6. Speiser PW, Azziz R, Baskin LS, Ghizzoni L, Hensle TW, Merke DP, Meyer-
Bahlburg HFL, Miller WL, Montori VM, Oberfield SE, Ritzen M, White PC:
Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase
Deficiency: An Endocrine Society Clinical Practice Guideline. J Clin
Endocrinol Metab 2010, 95(Suppl 9):4133-4160.
7. RIVM: Informatieblad in het kader van het landelijke neonatale
screeningsprogramma (Information leaflet of the national neonatal screening
program) Bilthoven; 2006.
8. Arlt W, Willis DS, Wild SH, Krone N, Doherty EJ, Hahner S, Han TS, Carroll PV,
Conway GS, Rees DA, Stimson RH, Walker BR, Connell JMC, Ross RJ, the
United Kingdom Congenital Adrenal Hyperplasia Adult Study Executive
(CaHASE): Health status of adults with congenital adrenal hyperplasia: A
cohort study of 203 patients. J Clin Endocrinol Metab 2010, 95(Suppl
11):5110-5121.
9. Westert GP, Schellevis FG, de Bakker DH, Groenewegen PP, Bensing JM, van
der Zee J: Monitoring health inequalities through general practice: the
Second Dutch National Survey of General Practice. Eur J Public Health
2005, 15(Suppl 1):59-65.
10. Heijmans MJWM, Rijken M: De impact van de ziekte van Addison, AGS of het
syndroom van Cushing op het dagelijks leven en de zorg: een onderzoek
vanuit patiëntenperspectief (The impact of Addison’s disease, CAH and
Cushing’s syndrome on daily life and healthcare: a study from the patient’s
perspective.) Utrecht: NIVEL; 2006.
11. Calsbeek H: The social position of adolescents and young adults with chronic
digestive disorders Utrecht: NIVEL; 2003.
12. Sanches S, Wiegers T: Het fysiek, sociaal en maatschappelijk functioneren van
kinderen met AGS (en hun ouders) (The physical, social and societal
functioning of children with CAH (and their parents) Utrecht: NIVEL; 2010.
13. Erichsen MM, Løvås K, Skinningsrud B, Wolff AB, Undlien DE, Svartberg J,
Fougner KJ, Berg TJ, Bollerslev J, Mella B, Carlson JA, Erlich H, Husebye ES:
Clinical, immunological, and genetic features of autoimmune primary
adrenal insufficiency: Observations from a Norwegian registry. J Clin
Endocrinol Metab 2009, 94:4882-4890.
14. Løvås K, Loge JH, Husebye ES: Subjective health status in Norwegian
Patients with Addison’s disease. Clin Endocrinol (Oxf) 2002, 56:581-588.
15. Bleicken B, Hahner S, Loeffler M, Ventz M, Allolio B, Quinkler M: Impaired
subjective health status in chronic adrenal insufficiency: impact of
different glucocorticoid replacement regimens. Eur J Endocrinol 2008,
159:811-817.
16. Hahner S, Loeffler M, Fassnacht M, Weisman D, Koschker AC, Quinkler M,
Decker O, Arlt W, Allolio B: Impaired subjective health status in 256
patients with adrenal insufficiency based on cross sectional analysis. J
Clin Endocrinol Metab 2007, 92:3912-3922.
17. Gurnell EM, Hunt PJ, Curran SE, Conway CL, Pullenayegum EM, Huppert FA,
Compston JE, Herbert J, Chatterjee VK: Longterm DHEA replacement in
primary adrenal insufficiency: a randomized, controlled trial. J Clin
Endocrinol Metab 2008, 93:400-409.
18. Witchel SF: The medical home concept and Congenital Adrenal
Hyperplasia: a comfortable habitat! Int J Ped Endcorinol 2010, 2010:561526.
doi:10.1186/1687-9856-2012-2
Cite this article as: Sanches et al.: Physical, social and societal
functioning of children with congenital adrenal hyperplasia (CAH) and
their parents, in a Dutch population. International Journal of Pediatric
Endocrinology 2012 2012:2.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Sanches et al. International Journal of Pediatric Endocrinology 2012, 2012:2
http://www.ijpeonline.com/content/2012/1/2
Page 8 of 8
